1. APRIL MARKETS
2. UP STARS/DOWN STARS
3. GOLDEN OPPORTUNITIES
4. QUOTES
5. ON THE WEB
6. LETTERS
What is
next? The SHOCK of how little revenue
the IRS will collect by April 15th.
BOTTOM LINE: We are
modesty bearish given that ALL the BAD news is NOT (yet) built
into current market prices.
Sell, Distribute, Profit Protect or Write call options while the market
is overpriced in April:
TRADERS:
THESE ARE VERY DIFFICULT MARKETS- STAY CAUTIOUS.
Buy/Accumulate
stocks Dow 6600-7240 Distribute 8000 Sell 8300.
INVESTORS:
My long term view is well known. Focus on protecting against downside risk and
only buy and hold stocks with sustainable earnings at Deeply Discounted Value
pricing.
Invest
only in stocks at bargain basement price that you are willing to hold until
2010-2011.
FAIR VALUE RANGE: DOW
8000-8300 NAS 1500-1530 SPX 825-860
LONG/SHORT
PORTFOLIO: L1/S2.
KEY
DATES: APRIL 8, 9
DJIA:
800 PIVOT
SPX:
840 SUPPORT? S1 825 S2 810 S3 800 R1 850 R2 860
R3 880
NASDAQ:
1380 SUPPORT 1500 RESISTANCE
XAU:
135 PIVOT120 SUPPORT 145 RESISTANCE
JUNE
GOLD: 900 PIVOT 880 SUPPORT R1 908 R2 925 IR 940
MAY SILVER: 13
PIVOT 12.25 SUPPORT
XOI:
900 PIVOT
DEC
OIL: 60 PIVOT 56 SUPPORT 65
RESISTANCE
The current Market Marker Sentiment is Some worry, then bargain hunting, then return to worry.
2008 CLOSE:
DJIA 8776,
SPX 903 & NASDAQ 1577
2007 CLOSE:
DJIA 13264, SPX 1468 &
NASDAQ 2655
2006 CLOSE:
DJIA 12463, SPX 1418 &
NASDAQ 2415
2005 CLOSE:
DJIA 10717, SPX 1248 & NASDAQ
2205
DIJA:
12 ~ FV 6 UV; 13 offer 4%+ Dividends 9 offer 5%+ Dividends.
THINK
TRADITIONAL SWISS AND PRESERVE CAPITAL: FOCUS ON PROTECTING AGAINST DOWNSIDE
RISK.
2. BUSINESS & BANQUETS
At the Very Independent Research Metals
Conference last week, we enjoyed several base and precious metal company’s
presentations. Three long time favorites presenting were:
Agnico-Eagle Mines (AEM), our current favorite
midcap gold, Virginia Mines (VIA-T), the first in class
At the Biocentury Future Leaders in the Biotech
Industry conference, we discovered one very interesting company: Infinity
Pharmaceuticals (INFI). Like ALL
companies we are considering investing (not trading) these days. INFI has
plenty of cash (or cash flow) into 2011!
We also favorably reviewed the progress of Vivus
(VVUS) whose Phase III Qnexa results on obesity are forthcoming soon. It
is also Cash Rich.
Potentially promising and on Watch are Arca
Biopharma (ABIO) and Regulus Therapeutics (Private).
3. Given
Gold’s Fair Value is currently $908, and hence currently is UNDER VALUED, we
are ALMOST ready to accumulate. This
will be done over the next 60 days.
Our current assumption is that Gold will trade
above $875 and Silver $12 support on Friday.
If not, we will be buying at a lower price before May. :).
Stephen
Docherty, head of global equities, Aberdeen Asset
HW:
A REAL solution, not more “Mark to Fantasy” accounting!
“We have seen quite lot of indications that have stopped
deteriorating, not so much at the company level but more on the economic front.
“There is quite of lot of newsflow that is building a base for the market. Now
it’s a case of what kind of recovery we can get.”
Kevin Lilley, fund manager, Royal London Asset Management,
HW: This view, while popular, is more propaganda than
reality.
“People
are going to need to understand that the corrective process is not a short one,
it’s not an easy one, and there’s only so much policy makers can do.”
Joshua
Shapiro, chief
HW:
You mean I will have to wait more than one hour?!
5. Peter J. Tanous
Says It May Take Years for Stocks to Bounce Back
Six
reasons I am calling a bottom and declaring a new bull market
Paul Krugman: China’s Dollar Trap
6. READER: You continue to say only by QUALITY STOCKS with cash and little or
no debt going forward to 2010/2011. Does this mean the market is going be
extremely volatility as in the past several months or will it be even more
wild? If this will be the case than GOLD seems to be a better
HW: Market
volatility will continue in Q2 2009, whether more or less hardly matters. As for gold investing, it is of interest as a
hedge short term, and investment intermediate term.
(c)
2009 All
rights reserved THE
ASTROLOGERS FUND, INC
"Always a Stellar Performance"
wsnw@afund.com
Phone 212/949-7275 Fax
212 608
6964 32 West 39th
Street 12th
Fl New York, NY
10018
Author:
INVESTING BY THE STARS and THE STUDY OF ASTROLOGY
INVESTORS
ARE REMINDED TO PERFORM THEIR OWN DUE DILIGENCE BEFORE MAKING ANY
INVESTMENT
DECISION. ALWAYS INDEPENDENTLY INVESTIGATE AND FULLY UNDERSTAND ALL
RISK BEFORE
MAKING ANY INVESTMENT.
DISCLAIMER:
PAST RESULTS ARE NOT NECESSARILY
INDICATIVE OF FUTURE FORECASTING ACCURACY OR PROFITABLE TRADING RESULTS.
The
Astrologers Fund Inc. accepts No Liability Whatsoever for Any Loss
arising from
Any Use of its Report or its Contents. The
Astrologers Fund (AFUND) is not a registered broker dealer or a
registered
investment advisor. The Astrologers Fund
Inc. or its Clients
Usually Holds Positions in the Stocks and/or Market Instruments
Mentioned and
May Buy or Sell At Any Time Without Notice depending on market
conditions and
personal financial conditions. This Information Is In No Way A
Representation
to Buy Or Sell Securities, Bonds, Options Or Futures.
This information is not intended to be used
as the sole basis of any investment decisions, nor should it be
construed as
advice designed to meet the investment needs of any particular investor.
Please
read our Disclaimer
for more information and note that my clients and I are shareholders
and may
act in the open market.
ALWAYS
CHECK WITH YOUR LICENSED FINANCIAL PLANNER OR BROKER BEFORE BUYING OR
SELLING
ON THE RECOMMENDATIONS OF THE ASTROLOGERS FUND INC.